{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:13:50Z","timestamp":1740140030530,"version":"3.37.3"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1208\/s12249-019-1548-z","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T18:07:28Z","timestamp":1571249248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Orphan Formulations in Pediatric Schistosomiasis Treatment: Development and Characterization of Praziquantel Nanoparticle\u2014Loaded Powders for Reconstitution"],"prefix":"10.1208","volume":"20","author":[{"given":"M. A.","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. V.","family":"Ram\u00edrez Rigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0687-0096","authenticated-orcid":false,"given":"N. L.","family":"Gonzalez Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,16]]},"reference":[{"key":"1548_CR1","unstructured":"WHO, World Health Organization. Schistosomiasis, Disease. \nhttps:\/\/www.who.int\/schistosomiasis\/disease\/en\/\n\n. Accessed 9th May 2019."},{"key":"1548_CR2","unstructured":"WHO Schistosomiasis Fact Sheet. \nhttps:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/schistosomiasis. Accessed 9th May 2019"},{"key":"1548_CR3","unstructured":"World Health Organization. Report of a meeting to review the results of studies on the treatment of Schistosomiasis in preschool-age children. Geneva, Switzerland, 2010. Available: \nhttps:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44639\/9789241501880_eng.pdf?sequence=1\n\n. Accessed 9th May 2019."},{"key":"1548_CR4","volume-title":"Model list of essential medicines","author":"WHO","year":"2017","unstructured":"WHO. Model list of essential medicines. 20th ed. Geneva: World Health Organization; 2017. Available in: \nhttps:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/273826\/EML-20-eng.pdf?ua=1\n\n. Accessed 9th May 2019","edition":"20"},{"issue":"13","key":"1548_CR5","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1017\/S0031182009990400","volume":"136","author":"A. FENWICK","year":"2009","unstructured":"Fenwick A, Webster JP, Bosque-Oliva E, Blair L, Fleming FM, Zhang Y, et al. The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002\u20132008. Parasitology 2009. 136(13):1719\u201330. \nhttps:\/\/doi.org\/10.1017\/S0031182009990400\n\n.","journal-title":"Parasitology"},{"issue":"3","key":"1548_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/BF03189418","volume":"4","author":"K Patzschke","year":"1979","unstructured":"Patzschke K, Putter J, Wegner LA, Horster FA, Diekmann HW. Serum concentrations and renal excretion in humans after oral administration of praziquantel - results of three determination methods. Eur J Drug Metab Pharmacokinet. 1979;4(3):149\u201356. \nhttps:\/\/doi.org\/10.1007\/BF03189418\n\n.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"1","key":"1548_CR7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ijpharm.2015.09.019","volume":"495","author":"R Trastullo","year":"2015","unstructured":"Trastullo R, Dolci LS, Passerini N, Albertini B. Development of flexible and dispersible oral formulations containing praziquantel for potential schistosomiasis treatment of pre-school age children. Int J Pharm. 2015;495(1):536\u201350. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2015.09.019\n\n.","journal-title":"Int J Pharm"},{"key":"1548_CR8","unstructured":"WHO. World Health Organization. Schistosomiasis. Strategy; 2016. \nhttp:\/\/www.who.int\/schistosomiasis\/strategy\/en\/\n\n. Accessed 9th May 2019."},{"key":"1548_CR9","unstructured":"Pediatric Praziquantel Consortium. \nhttps:\/\/www.pediatricpraziquantelconsortium.org\/schistosomiasis\n\n. Accessed 9th May 2019."},{"issue":"1-2","key":"1548_CR10","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ijpharm.2017.06.084","volume":"529","author":"M M\u00fcnster","year":"2017","unstructured":"M\u00fcnster M, Mohamed-Ahmed AH, Immohr LI, Schoch C, Schmidt C, Tuleu C, et al. Comparative in vitro and in vivo taste assessment of liquid praziquantel formulations. Int J Pharm. 2017;529(1-2):310\u20138. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2017.06.084\n\n.","journal-title":"Int J Pharm"},{"issue":"1-2","key":"1548_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ijpharm.2006.03.028","volume":"318","author":"N Passerini","year":"2006","unstructured":"Passerini N, Albertini B, Perissutti B, Rodriguez L. Evaluation of melt granulation and ultrasonic spray congealing as techniques to enhance the dissolution of praziquantel. Int J Pharm. 2006;318(1-2):92\u2013102. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2006.03.028\n\n.","journal-title":"Int J Pharm"},{"issue":"1-2","key":"1548_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.01.033","volume":"295","author":"D Gonz\u00e1lez-Esquivel","year":"2005","unstructured":"Gonz\u00e1lez-Esquivel D, Rivera J, Castro N, Yepez-Mulia L, Helgi JC. In vitro characterization of some biopharmaceutical properties of praziquantel. Int J Pharm. 2005;295(1-2):93\u20139. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2005.01.033\n\n.","journal-title":"Int J Pharm"},{"issue":"2","key":"1548_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejpb.2004.03.001","volume":"58","author":"M Lindenberg","year":"2004","unstructured":"Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm. 2004;58(2):265\u201378. \nhttps:\/\/doi.org\/10.1016\/j.ejpb.2004.03.001\n\n.","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"1548_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1208\/s12248-016-9885-2","volume":"18","author":"R Shawahna","year":"2016","unstructured":"Shawahna R. Pediatric biopharmaceutical classification system: using age-appropriate initial gastric volume. AAPS J. 2016;18(3):728\u201336. \nhttps:\/\/doi.org\/10.1208\/s12248-016-9885-2\n\n.","journal-title":"AAPS J"},{"issue":"1","key":"1548_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00118-6","volume":"47","author":"RH M\u00fcller","year":"2001","unstructured":"M\u00fcller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy rationale for development and what we can expect for the future. Adv Drug Deliv Rev. 2001;47(1):3\u201319. \nhttps:\/\/doi.org\/10.1016\/S0169-409X(00)00118-6\n\n.","journal-title":"Adv Drug Deliv Rev"},{"key":"1548_CR16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.colsurfb.2018.08.016","volume":"172","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Fang Q, Niu B, Wu B, Zhao Y, Quan G, et al. Comparative studies on amphotericin B nanosuspensions prepared by a high pressure homogenization method and an antisolvent precipitation method. Colloid Surf B Biointerfaces. 2018;172:372\u20139. \nhttps:\/\/doi.org\/10.1016\/j.colsurfb.2018.08.016\n\n.","journal-title":"Colloid Surf B Biointerfaces"},{"issue":"12","key":"1548_CR17","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1021\/ja02086a00","volume":"19","author":"AA Noyes","year":"1897","unstructured":"Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J Am Chem Soc. 1897;19(12):930\u20134. \nhttps:\/\/doi.org\/10.1021\/ja02086a00\n\n.","journal-title":"J Am Chem Soc"},{"issue":"4","key":"1548_CR18","first-page":"35","volume":"2","author":"P Lakshmi","year":"2010","unstructured":"Lakshmi P, Kumar GA. Nanosuspension technology: a review. Int J Pharm Sci. 2010;2(4):35\u201340.","journal-title":"Int J Pharm Sci"},{"issue":"1","key":"1548_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejpb.2005.05.009","volume":"62","author":"CM Keck","year":"2006","unstructured":"Keck CM, M\u00fcller RH. Drug nanocrystals of poorly soluble drugs produced by high-pressure homogenization. Eur J Pharm Biopharm. 2006;62(1):3\u201316. \nhttps:\/\/doi.org\/10.1016\/j.ejpb.2005.05.009\n\n.","journal-title":"Eur J Pharm Biopharm"},{"key":"1548_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ejps.2015.12.030","volume":"83","author":"A Foglio Bonda","year":"2016","unstructured":"Foglio Bonda A, Rinaldi M, Segale L, Palugan L, Cerea M, Vecchio C, et al. Nanonized itraconazole powders for extemporary oral suspensions: role of formulation components studied by a mixture design. Eur J Pharm Sci. 2016;83:175\u201383. \nhttps:\/\/doi.org\/10.1016\/j.ejps.2015.12.030\n\n.","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"1548_CR21","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.addr.2011.02.001","volume":"63","author":"L Wu","year":"2011","unstructured":"Wu L, Zhang J, Watanabe W. Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev. 2011;63(6):456\u201369. \nhttps:\/\/doi.org\/10.1016\/j.addr.2011.02.001\n\n.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1-2","key":"1548_CR22","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ijpharm.2013.12.039","volume":"464","author":"S Kumar","year":"2014","unstructured":"Kumar S, Gokhale R, Burgess DJ. Quality by design approach to spray drying processing of crystalline nanosuspensions. Int J Pharm. 2014;464(1-2):234\u201342. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2013.12.039\n\n.","journal-title":"Int J Pharm"},{"issue":"7","key":"1548_CR23","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1002\/jps.24015","volume":"103","author":"X Zhang","year":"2014","unstructured":"Zhang X, Guan J, Ni R, Li LC, Mao S. Preparation and solidification of redispersible nanosuspensions. J Pharm Sci. 2014;103(7):2166\u201376. \nhttps:\/\/doi.org\/10.1002\/jps.24015\n\n.","journal-title":"J Pharm Sci"},{"issue":"10","key":"1548_CR24","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1007\/s11095-008-9625-0","volume":"25","author":"MV Chaubal","year":"2008","unstructured":"Chaubal MV, Popescu C. Conversion of nanosuspensions into dry powders by spray drying: a case study. Pharm Res. 2008;25(10):2302\u20138. \nhttps:\/\/doi.org\/10.1007\/s11095-008-9625-0\n\n.","journal-title":"Pharm Res"},{"issue":"1","key":"1548_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijpharm.2008.07.023","volume":"364","author":"B Van Eerdenbrugh","year":"2008","unstructured":"Van Eerdenbrugh B, Van den Mooter G, Augustijns P. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm. 2008;364(1):64\u201375. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2008.07.023\n\n.","journal-title":"Int J Pharm"},{"key":"1548_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.msec.2018.07.050","volume":"93","author":"MA Gonzalez","year":"2018","unstructured":"Gonzalez MA, Ram\u00edrez-Rigo MV, Gonzalez Vidal NG. Praziquantel systems with improved dissolution rate obtained by high pressure homogenization. Mater Sci Eng C Mater. 2018;93:28\u201335. \nhttps:\/\/doi.org\/10.1016\/j.msec.2018.07.050\n\n.","journal-title":"Mater Sci Eng C Mater"},{"issue":"10","key":"1548_CR27","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3109\/03639045.2016.1151036","volume":"42","author":"AJ Paredes","year":"2016","unstructured":"Paredes AJ, Llabot JM, Sanchez Bruni S, Allemandi D, Palma SD. Self-dispersible nanocrystals of albendazole produced by high pressure homogenization and spray-drying. Drug Dev Ind Pharm. 2016;42(10):1564\u201370. \nhttps:\/\/doi.org\/10.3109\/03639045.2016.1151036\n\n.","journal-title":"Drug Dev Ind Pharm"},{"issue":"1-2","key":"1548_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijpharm.2005.05.014","volume":"299","author":"J Hecq","year":"2005","unstructured":"Hecq J, Deleers M, Fanara D, Vranckx H, Amighi K. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int J Pharm. 2005;299(1-2):167\u201377. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2005.05.014\n\n.","journal-title":"Int J Pharm"},{"key":"1548_CR29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ejps.2017.08.034","volume":"109","author":"M M\u00fcnster","year":"2017","unstructured":"M\u00fcnster M, Schoch C, Schmidt C, Breitkreutz J. Multiparticulate system combining taste masking and immediate release properties for the aversive compound praziquantel. Eur J Pharm Sci. 2017;109:446\u201354. \nhttps:\/\/doi.org\/10.1016\/j.ejps.2017.08.034\n\n.","journal-title":"Eur J Pharm Sci"},{"key":"1548_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/jps.24223","volume":"104","author":"GA Campbell","year":"2015","unstructured":"Campbell GA, Vallejo E. Primary packaging considerations in developing medicines for children: oral liquid and powder for constitution. J Pharm Sci. 2015;104:52\u201362. \nhttps:\/\/doi.org\/10.1002\/jps.24223\n\n.","journal-title":"J Pharm Sci"},{"issue":"4","key":"1548_CR31","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.xphs.2018.11.013","volume":"108","author":"RG Strickley","year":"2019","unstructured":"Strickley RG. Pediatric oral formulations: an updated review of commercially available pediatric oral formulations since 2007. J Pharm Sci. 2019;108(4):1335\u201365. \nhttps:\/\/doi.org\/10.1016\/j.xphs.2018.11.013\n\n.","journal-title":"J Pharm Sci"},{"key":"1548_CR32","unstructured":"Safety & Toxicity of Exci\u00edents for Paediatrics Database (STEP Database). Available in: \nhttp:\/\/www.eupfi.org\/step-database-info\/\n\n. Accessed August 10th, 2019"},{"issue":"3","key":"1548_CR33","doi-asserted-by":"publisher","first-page":"254","DOI":"10.2146\/ajhp050208","volume":"63","author":"MC Nahata","year":"2006","unstructured":"Nahata MC, Morosco RS, Brady MT. Extemporaneous sildenafil citrate oral suspensions for the treatment of pulmonary hypertension in children. Am J Health Syst Pharm. 2006;63(3):254\u20137. \nhttps:\/\/doi.org\/10.2146\/ajhp050208\n\n.","journal-title":"Am J Health Syst Pharm"},{"issue":"7","key":"1548_CR34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2146\/ajhp090163","volume":"67","author":"KL Skillman","year":"2010","unstructured":"Skillman KL, Caruthers RL, Johnson CE. Stability of an extemporaneously prepared clopidogrel oral suspension. Am J Health Syst Pharm. 2010;67(7):559\u201361. \nhttps:\/\/doi.org\/10.2146\/ajhp090163\n\n.","journal-title":"Am J Health Syst Pharm"},{"key":"1548_CR35","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1136\/ejhpharm-2012-000159","volume":"19","author":"M Helin-Tanninen","year":"2012","unstructured":"Helin-Tanninen M, Autio K, Keski-Rahkonen P, Naaranlahti T, J\u00e4rvinen K. Comparison of six different suspension vehicles in compounding of oral extemporaneous nifedipine suspension for paediatric patients. Eur J Hosp Pharm. 2012;19:432\u20137. \nhttps:\/\/doi.org\/10.1136\/ejhpharm-2012-000159\n\n.","journal-title":"Eur J Hosp Pharm"},{"key":"1548_CR36","unstructured":"Calcagno AJ, Palma SD, Cabrera F, Ram\u00edrez-Rigo MV, Pi\u00f1a J. Meloxicam-Poloxamer solid dispersions by spray drying. Poster presentation. 3\u00b0 Reuni\u00f3n Internacional de Ciencias Farmac\u00e9uticas (RICiFa 2014) C\u00f3rdoba, Argentina, 2014."},{"key":"1548_CR37","unstructured":"Farmacotecnia, bolet\u00edn informativo. Sociedad Espa\u00f1ola de Farmacia Hospitalaria. Espa\u00f1a; 2014. Available in: \nhttps:\/\/gruposdetrabajo.sefh.es\/farmacotecnia\/images\/stories\/Boletines\/BOLETIN32014final.pdf. Accessed 9th May 2019"},{"issue":"3","key":"1548_CR38","doi-asserted-by":"publisher","first-page":"441","DOI":"10.18433\/J38887","volume":"16","author":"A Haywood","year":"2013","unstructured":"Haywood A, Glass BD. Liquid dosage forms extemporaneously prepared from commercially available products\u2013considering new evidence on stability. J Pharm Pharm Sci. 2013;16(3):441\u201355. \nhttps:\/\/doi.org\/10.18433\/J38887\n\n.","journal-title":"J Pharm Pharm Sci"},{"issue":"2","key":"1548_CR39","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ijpharm.2012.05.045","volume":"440","author":"F Palazzo","year":"2013","unstructured":"Palazzo F, Giovagnoli S, Schoubben A, Blasi P, Rossi C, Ricci M. Development of a spray-drying method for the formulation of respirable microparticles containing ofloxacin\u2013palladium complex. Int J Pharm. 2013;440(2):273\u201382. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2012.05.045\n\n.","journal-title":"Int J Pharm"},{"key":"1548_CR40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.powtec.2015.08.016","volume":"286","author":"CA Di Battista","year":"2015","unstructured":"Di Battista CA, Constenla D, Ram\u00edrez-Rigo MV, Pi\u00f1a J. The use of arabic gum, maltodextrin and surfactants in the microencapsulation of phytosterols by spray drying. Powder Technol. 2015;286:193\u2013201. \nhttps:\/\/doi.org\/10.1016\/j.powtec.2015.08.016\n\n.","journal-title":"Powder Technol"},{"key":"1548_CR41","unstructured":"Argentine Pharmacopeia, 7th Ed; Administraci\u00f3n Nacional de Medicamentos, Alimentos y Tecnolog\u00eda M\u00e9dica (ANMAT): Buenos Aires, Argentina; 2013."},{"key":"1548_CR42","volume-title":"USP 41-NF 36","author":"The United States Pharmacopoeia and National Formulary","year":"2018","unstructured":"The United States Pharmacopoeia and National Formulary. USP 41-NF 36. Rockville: The United States Pharmacopoeial Convention, Inc.; 2018."},{"issue":"11","key":"1548_CR43","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1248\/cpb.47.1629","volume":"47","author":"P De la Torre","year":"1999","unstructured":"De la Torre P, Torrado S, Torrado S. Preparation, dissolution and characterization of praziquantel solid dispersions. Chem Pharm Bull. 1999;47(11):1629\u201333. \nhttps:\/\/doi.org\/10.1248\/cpb.47.1629\n\n.","journal-title":"Chem Pharm Bull"},{"issue":"1","key":"1548_CR44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.2042-7158.1975.tb09378.x","volume":"27","author":"KA Khan","year":"1975","unstructured":"Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol. 1975;27(1):48\u20139. \nhttps:\/\/doi.org\/10.1111\/j.2042-7158.1975.tb09378.x\n\n.","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"1548_CR45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","volume":"12","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C, et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010;12(3):263\u201371. \nhttps:\/\/doi.org\/10.1208\/s12248-010-9185-1\n\n.","journal-title":"AAPS J"},{"issue":"2","key":"1548_CR46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","volume":"13","author":"P Costa","year":"2001","unstructured":"Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123\u201333. \nhttps:\/\/doi.org\/10.1016\/S0928-0987(01)00095-1\n\n.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"1548_CR47","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0039-9140(99)00129-0","volume":"50","author":"O Mengual","year":"1999","unstructured":"Mengual O, Meunier G, Cayr\u00e9 I, Puech K, Snabre P. TURBISCAN MA 2000: multiple light scattering measurement for concentrated emulsion and suspension instability analysis. Talanta. 1999;50(2):445\u201356. \nhttps:\/\/doi.org\/10.1016\/S0039-9140(99)00129-0\n\n.","journal-title":"Talanta"},{"issue":"4","key":"1548_CR48","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2174\/1573406410666141110153502","volume":"11","author":"C Celia","year":"2015","unstructured":"Celia C, Locatelli M, Cilurzo F, Cosco D, Gentile E, Scalise D, et al. Long term stability evaluation of prostacyclin released from biomedical device through Turbiscan lab expert. Med Chem. 2015;11(4):391\u20139. \nhttps:\/\/doi.org\/10.2174\/1573406410666141110153502\n\n.","journal-title":"Med Chem"},{"issue":"1-2","key":"1548_CR49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0378-5173(02)00333-2","volume":"246","author":"AP Vilches","year":"2002","unstructured":"Vilches AP, Jimenez-Kairuz A, Alovero F, Olivera ME, Allemandi DA, Manzo RH. Release kinetics and up-take studies of model fluoroquinolones from carbomer hydrogels. Int J Pharm. 2002;246(1-2):17\u201324. \nhttps:\/\/doi.org\/10.1016\/S0378-5173(02)00333-2\n\n.","journal-title":"Int J Pharm"},{"issue":"1","key":"1548_CR50","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ijpharm.2013.06.050","volume":"454","author":"PF Yue","year":"2013","unstructured":"Yue PF, Li Y, Wan J, Yang M, Zhu WF. Wang, CH. Study on formability of solid nanosuspensions during nanodispersion and solidification: I. Novel role of stabilizer\/drug property. Int J Pharm. 2013;454(1):269\u201377. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2013.06.050\n\n.","journal-title":"Int J Pharm"},{"issue":"1","key":"1548_CR51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/17425247.2017.1321634","volume":"15","author":"A Al-Khattawi","year":"2018","unstructured":"Al-Khattawi A, Bayly A, Phillips A, et al. The design and scale-up of spray dried particle delivery systems. Expert Opin Drug Deliv. 2018;15(1):47\u201363. \nhttps:\/\/doi.org\/10.1080\/17425247.2017.1321634\n\n.","journal-title":"Expert Opin Drug Deliv"},{"key":"1548_CR52","unstructured":"Arpagaus C, Schwartzbach H. Scale-up from bench-top research to labotory production. B\u00fcchi Mini Spray Dyer B-290. Information Bulletin N\u00b0 52\/2008."},{"key":"1548_CR53","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.msec.2014.04.040","volume":"41","author":"NE Ceschan","year":"2014","unstructured":"Ceschan NE, Bucal\u00e1 V, Ram\u00edrez-Rigo MV. New alginic acid\u2013atenolol microparticles for inhalatory drug targeting. Mater Sci Eng C Mater. 2014;41:255\u201366. \nhttps:\/\/doi.org\/10.1016\/j.msec.2014.04.040\n\n.","journal-title":"Mater Sci Eng C Mater"},{"key":"1548_CR54","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.colsurfb.2014.09.055","volume":"123","author":"KP Seremeta","year":"2014","unstructured":"Seremeta KP, Tur MIR, P\u00e9rez SM, H\u00f6cht C, Taira C, Hern\u00e1ndez ODL, et al. Spray-dried didanosine-loaded polymeric particles for enhanced oral bioavailability. Colloid Surf B Biointerfaces. 2014;123:515\u201323. \nhttps:\/\/doi.org\/10.1016\/j.colsurfb.2014.09.055\n\n.","journal-title":"Colloid Surf B Biointerfaces"},{"key":"1548_CR55","first-page":"430","volume-title":"Handbook of pharmaceutical excipients","year":"2006","unstructured":"Rowe RC, Sheskey PJ, Owen SC, editors. Handbook of pharmaceutical excipients. 5th ed. Pharmaceutical Press: London; 2006. p. 430\u20133.","edition":"5"},{"issue":"1","key":"1548_CR56","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s10973-011-1871-4","volume":"108","author":"AL Ribeiro de Souza","year":"2011","unstructured":"Ribeiro de Souza AL, Andreani T, Nunes FM, Cassimiro DL, de Almeida AE, Ribeiro CA, et al. Loading of praziquantel in the crystal lattice of solid lipid nanoparticles: studies by DSC and SAXS. J Therm Anal Calorim. 2011;108(1):353\u201360. \nhttps:\/\/doi.org\/10.1007\/s10973-011-1871-4\n\n.","journal-title":"J Therm Anal Calorim"},{"key":"1548_CR57","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/0032-3861(85)90114-4","volume":"26","author":"DT Turner","year":"1985","unstructured":"Turner DT, Schwartz A. The glass transition temperature of poly(N-vinyl pyrrolidone) by differential scanning calorimetry. Polymer. 1985;26:757\u201362. \nhttps:\/\/doi.org\/10.1016\/0032-3861(85)90114-4\n\n.","journal-title":"Polymer"},{"key":"1548_CR58","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/b138598","volume-title":"Polyvinylpyrrolidone \u2013 excipients for pharmaceuticals","author":"V B\u00fchler","year":"2005","unstructured":"B\u00fchler V. Polyvinylpyrrolidone \u2013 excipients for pharmaceuticals. Germany: Springer; 2005. p. 87. \nhttps:\/\/doi.org\/10.1007\/b138598\n\n."},{"issue":"8","key":"1548_CR59","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/jps.2600840814","volume":"84","author":"M Yoshioka","year":"1995","unstructured":"Yoshioka M, Hancock B, Zografi G. Inhibition of indomethacin crystallization in poly(vinylpyrro1idone) coprecipitates. J Pharm Sci. 1995;84(8):983\u20136. \nhttps:\/\/doi.org\/10.1002\/jps.2600840814\n\n.","journal-title":"J Pharm Sci"},{"issue":"2","key":"1548_CR60","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ijpharm.2017.05.053","volume":"533","author":"B Perissutti","year":"2017","unstructured":"Perissutti B, Passerini N, Trastullo R, Keiser J, Zanolla D, Zingone G, et al. An explorative analysis of process and formulation variables affecting comilling in a vibrational mill: the case of praziquantel. Int J Pharm. 2017;533(2):402\u201312. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2017.05.053\n\n.","journal-title":"Int J Pharm"},{"issue":"1","key":"1548_CR61","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0378-5173(96)04687-X","volume":"143","author":"V Tantishaiyakul","year":"1996","unstructured":"Tantishaiyakul V, Kaewnopparat N, Ingkatawornwong S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone K-30. Int J Pharm. 1996;143(1):59\u201366. \nhttps:\/\/doi.org\/10.1016\/S0378-5173(96)04687-X\n\n.","journal-title":"Int J Pharm"},{"issue":"1-2","key":"1548_CR62","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0731-7085(98)00171-X","volume":"18","author":"P Mura","year":"1998","unstructured":"Mura P, Faucci MT, Manderioli A, Bramanti G, Ceccarelli L. Compatibility study between ibuproxam and pharmaceutical excipients using differential scanning calorimetry, hot-stage microscopy and scanning electron microscopy. J Pharm Biomed Anal. 1998;18(1-2):151\u201363. \nhttps:\/\/doi.org\/10.1016\/S0731-7085(98)00171-X\n\n.","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"1548_CR63","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jpba.2011.05.017","volume":"56","author":"B Tita","year":"2011","unstructured":"Tita B, Fulias A, Bandur G, Marian E, Tita D. Compatibility study between ketoprofen and pharmaceutical excipients used in solid dosage forms. J Pharm Biomed Anal. 2011;56(2):221\u20137. \nhttps:\/\/doi.org\/10.1016\/j.jpba.2011.05.017\n\n.","journal-title":"J Pharm Biomed Anal"},{"issue":"12","key":"1548_CR64","doi-asserted-by":"publisher","first-page":"9002","DOI":"10.1063\/1.459240","volume":"93","author":"CL Jackson","year":"1998","unstructured":"Jackson CL, McKenna GB. The melting behavior of organic materials confined in porous solids. J Chem Phys. 1998;93(12):9002\u201311. \nhttps:\/\/doi.org\/10.1063\/1.459240\n\n.","journal-title":"J Chem Phys"},{"issue":"6","key":"1548_CR65","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1002\/jps.23980","volume":"103","author":"C Kuehl","year":"2014","unstructured":"Kuehl C, El-Gendy N, Berkland C. Nanoclusters surface area allows nanoparticle dissolution with microparticle properties. J Pharm Sci. 2014;103(6):1787\u201398. \nhttps:\/\/doi.org\/10.1002\/jps.23980\n\n.","journal-title":"J Pharm Sci"},{"issue":"2","key":"1548_CR66","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.ijpharm.2016.08.009","volume":"511","author":"ED Costa","year":"2016","unstructured":"Costa ED, Priotti J, Orlandi S, Leonardi D, Lamas MC, Nunes TG, et al. Unexpected solvent impact in the crystallinity of praziquantel\/poly (vinylpyrrolidone) formulations. A solubility, DSC and solid-state NMR study. Int J Pharm. 2016;511(2):983\u201393. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2016.08.009\n\n.","journal-title":"Int J Pharm"},{"key":"1548_CR67","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0040-6031(94)01891-J","volume":"248","author":"OI Corrigan","year":"1995","unstructured":"Corrigan OI. Thermal analysis of spray dried products. Thermochim Acta. 1995;248:245\u201358. \nhttps:\/\/doi.org\/10.1016\/0040-6031(94)01891-J\n\n.","journal-title":"Thermochim Acta"},{"key":"1548_CR68","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jpba.2017.01.025","volume":"137","author":"M Cugov\u010dan","year":"2017","unstructured":"Cugov\u010dan M, Jablan J, Lovri\u0107 J, Cin\u010di\u0107 D, Gali\u0107 N, Jug M. Biopharmaceutical characterization of praziquantel cocrystals and cyclodextrin complexes prepared by grinding. J Pharm Biomed Anal. 2017;137:42\u201353. \nhttps:\/\/doi.org\/10.1016\/j.jpba.2017.01.025\n\n.","journal-title":"J Pharm Biomed Anal"},{"issue":"1-2","key":"1548_CR69","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijpharm.2005.06.027","volume":"302","author":"P Sinswat","year":"2005","unstructured":"Sinswat P, Gao X, Yacaman MJ, Williams RO III, Johnston KP. Stabilizer choice for rapid dissolving high potency itraconazole particles formed by evaporative precipitation into aqueous solution. Int J Pharm. 2005;302(1-2):113\u201324. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2005.06.027\n\n.","journal-title":"Int J Pharm"},{"issue":"1","key":"1548_CR70","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijpharm.2006.03.001","volume":"317","author":"SM Wong","year":"2006","unstructured":"Wong SM, Kellaway IW, Murdan S. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles. Int J Pharm. 2006;317(1):61\u20138. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2006.03.001\n\n.","journal-title":"Int J Pharm"},{"key":"1548_CR71","doi-asserted-by":"crossref","unstructured":"El-Subbagh HI, Al-Badr AA. Praziquantel. In: Florey, editor. Analytical profiles of drug substances and excipients, vol. 24: Academic Press Inc; 1998. p. 463\u2013500.","DOI":"10.1016\/S0099-5428(08)60760-1"},{"issue":"5","key":"1548_CR72","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s11051-008-9357-4","volume":"10","author":"L Gao","year":"2008","unstructured":"Gao L, Zhang D, Chen M. Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system. J Nanopart Res. 2008;10(5):845\u201362. \nhttps:\/\/doi.org\/10.1007\/s11051-008-9357-4\n\n.","journal-title":"J Nanopart Res"},{"issue":"2","key":"1548_CR73","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4155\/tde-2017-0090","volume":"9","author":"AJ Paredes","year":"2018","unstructured":"Paredes AJ, Sanchez Bruni S, Allemandi D, Lanusse C, Palma SD. Albendazole nanocrystals with improved pharmacokinetic performance in mice. Ther Deliv. 2018;9(2):89\u201397. \nhttps:\/\/doi.org\/10.4155\/tde-2017-0090\n\n.","journal-title":"Ther Deliv"},{"issue":"1","key":"1548_CR74","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0378-5173(86)90148-1","volume":"28","author":"BC Lippold","year":"1986","unstructured":"Lippold BC, Ohm A. Correlation between wettability and dissolution rate of pharmaceutical powders. Int J Pharm. 1986;28(1):67\u201374. \nhttps:\/\/doi.org\/10.1016\/0378-5173(86)90148-1\n\n.","journal-title":"Int J Pharm"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1548-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-019-1548-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1548-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T23:05:36Z","timestamp":1602716736000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-019-1548-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,16]]},"references-count":74,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1548"],"URL":"https:\/\/doi.org\/10.1208\/s12249-019-1548-z","relation":{},"ISSN":["1530-9932"],"issn-type":[{"type":"electronic","value":"1530-9932"}],"subject":[],"published":{"date-parts":[[2019,10,16]]},"assertion":[{"value":"19 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"318"}}